- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01904006
Impact of Human Embryo Culture System on Live Birth (AGRUPADO)
Improvement of Live Birth Rate With a New Standardized Human Embryo Culture System: a Prospective, Randomized, Controlled Trial
Previous studies in human and different mammals have proved that the embryo group culture (in the same culture medium drop) using a reduced volume is associated with a better embryo development. This is due to the effect of different autocrine and paracrine factors secreted by the embryos. Besides, previous studies with embryos from human and other mammals have shown that a high oxygen concentration may have a negative effect on embryo quality due to the generation of reactive oxygen species, which cause oxidative stress. The embryo culture at low oxygen tension is correlated to better success rates in IVF/ICSI treatments.
The purpose of this study is to evaluate the combined effect of the embryo group culture and the low oxygen tension on the embryo development and the results of the IVF/ICSI treatments. The specific goal is to compare the embryo group culture in a reduced volume of medium at a low oxygen tension (5%) with the standard individual culture at an atmospheric oxygen tension (20%). The first culture condition will be applied in a K-MINC incubator (COOK Medical®), whereas the second condition will be applied using a Heracell incubator (Heraeus®).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Seville
-
Sevilla, Seville, Spain, 41011
- IVI Sevilla
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- <38 years (with own oocytes) / <45 years (with oocyte donation).
- First treatment with own oocytes / any treatment with oocyte donation.
- ≥10 oocytes with a diameter of ≥10 mm.
Exclusion Criteria:
- Diseases that affect endometrial receptivity: endometriosis, hydrosalpinx, ovarian hyperstimulation syndrome, obesity, endocrinopathies, thrombophilia, congenital or acquired uterine anomalies.
- Patients under a treatment with genetic preimplantation diagnosis.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: New Culture Condition
Intervention group embryos cultured grouped under low oxygen tension in benchtop incubators.
|
Intervention group embryos cultured grouped (5 embryos per drop) under low oxygen tension (5%) in benchtop incubators.
|
|
Active Comparator: Standard Culture Condition
Control group embryos cultured individually under atmospheric oxygen tension in large-box incubators.
|
Control group embryos cultured individually (1 embryo per drop) under atmospheric oxygen tension (20%) in large-box incubators.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical pregnancy rate
Time Frame: April 2013 - October 2016
|
Confirmed when a gestational sac with heartbeat was observed in the uterus by ultrasound examination, performed 2-3 weeks after the positive result of the beta-hCG pregnancy test.
|
April 2013 - October 2016
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Implantation rate
Time Frame: April 2013 - October 2016
|
Number of embryos implanted per number of embryos transferred
|
April 2013 - October 2016
|
|
Live birth rate
Time Frame: April 2013 - October 2016
|
Number of newborns per pregnancy achieved
|
April 2013 - October 2016
|
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Fecundation rate
Time Frame: April 2013 - October 2016
|
April 2013 - October 2016
|
|
Mean number of viable embryos
Time Frame: April 2013 - October 2016
|
April 2013 - October 2016
|
|
Blastocyst rate
Time Frame: April 2013 - October 2016
|
April 2013 - October 2016
|
|
Mean number of embryos transferred
Time Frame: April 2013 - October 2016
|
April 2013 - October 2016
|
|
Live Birth rate per embryos transferred
Time Frame: April 2013 - October 2016
|
April 2013 - October 2016
|
|
Multiple pregnancy rate
Time Frame: April 2013 - October 2016
|
April 2013 - October 2016
|
|
Clinical miscarriage rate
Time Frame: April 2013 - October 2016
|
April 2013 - October 2016
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Myriam Ruiz, MSc, IVI Sevilla
- Study Director: Manuel Fernandez-Sánchez, PhD, IVI Sevilla
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IVISEV-003AGR
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Embryo Culture
-
Sun Yat-sen UniversityNot yet recruitingEmbryo Culture | Embryo Quality | Embryo Culture Media
-
Ganin Fertility CenterNot yet recruiting
-
Ibn Sina HospitalBanon IVF Center Assiut, EgyptCompleted
-
Ibn Sina HospitalBanoon IVF CenterCompleted
-
Reproductive & Genetic Hospital of CITIC-XiangyaUnknown
-
gyn-medicum GöttingenRecruiting
-
Fertilitetscentrum ABVitrolifeCompletedBlastocyst | Human | Antioxidants | Culture Media | EmbryoSweden
-
Hung Vuong HospitalCompletedEmbryo Development | IVF | Pregnancy Rates | Embryo Culture Media | Blastocyst IVFVietnam
-
VitrolifeCompletedBlastocyst | Human | Antioxidants | Oxygen | Culture Media | EmbryoJapan
Clinical Trials on New Culture Condition
-
Mỹ Đức HospitalCompletedIVM | PCOS (Polycystic Ovary Syndrome)Vietnam
-
Chang Gung Memorial HospitalCompletedStroke | Cerebrovascular Disorders | Central Nervous System DiseasesTaiwan
-
Hacettepe UniversityHasan Kalyoncu University; Giresun UniversityCompletedNursing Education | Cultural Sensitivity | Cultural CompetenceTurkey
-
Chinese University of Hong KongNot yet recruiting
-
UMC UtrechtDutch Heart FoundationNot yet recruitingHeart Failure NYHA Class II | Heart Failure NYHA Class III
-
Cardenal Herrera UniversityCompletedChronic Low-back Pain (cLBP)Spain
-
Rutgers, The State University of New JerseyRecruitingAggression | Problem Behavior | Self InjuryUnited States
-
University of LausanneEmpa - Swiss Federal Laboratories for Materials Testing and Research, ZürichCompleted
-
University of California, IrvineCompleted